This webinar will summarize the Sunshine Act or Open Payments Program requirements and provide practical solutions to the most common situations that are prevalent and necessary between sponsors and investigators.
The Sunshine Act or Open Payments Program requires manufacturers of drugs, medical devices, and biologics that participate in U.S. federal health care programs to report certain clinical investigator payments and items of value given to physicians and teaching hospitals. This Act was part of a healthcare reform bill adopted in March 2010. It came about due to requests for increased transparency about the financial relationships between physicians and the industry.
The Sunshine Act exposes the physicians and sponsors to new clinical trial reporting requirements and detail non-compliance which would lead to hefty fines. Templates for reporting format, exemptions to reporting requirements, and timelines for compliance and enforcement will be discussed.
Life science companies face the challenge of implementing the detailed reporting required by the Act as healthcare providers determine how to use their own data to anticipate public reporting of payments by life science companies to physicians and teaching hospitals.
This webinar will examine the implications of the Sunshine Act for healthcare providers and life science companies and discuss practical steps they can take to implement the Act and prepare for transparency.
The Sunshine Act exposes the physicians and sponsors to new clinical trial reporting requirements and detail non-compliance which would lead to hefty fines. Templates for reporting format, exemptions to reporting requirements, and timelines for compliance and enforcement will be discussed.
Life science companies face the challenge of implementing the detailed reporting required by the Act as healthcare providers determine how to use their own data to anticipate public reporting of payments by life science companies to physicians and teaching hospitals.
This webinar will examine the implications of the Sunshine Act for healthcare providers and life science companies and discuss practical steps they can take to implement the Act and prepare for transparency.
Danielle DeLucy Danielle DeLucy, MS, is owner of ASA Training and Consulting, LLC which provides Pharmaceutical and Biologics based companies with training and quality systems assistance in order to meet Regulatory compliance. Prior to this role, Danielle has been in the industry for 15 years serving in numerous Quality Management Roles, such as the Director of Product Quality, the oversight of Sterility Assurance practices and provided QA oversight of numerous filling and packaging operations. Danielle began her QA career as a Quality Control Pharmaceutical Microbiologist at a contract laboratory where she performed various tests for their clients. In the years after, she …
Risk and FDA Inspections: Anticipation, Preparation, Reacti…
Supervising a Human Error Free Environment: You can do a Lo…
The design was the leading cause of the most serious medica…
Wage and Hour Compliance : Avoiding Stiff Penalties Under F…
Data Integrity and Privacy: Compliance with 21 CFR Part 11,…
Enhancing Employee Engagement to Drive Organizational Perfo…
FMLA: The law, challenges, and application
Non-Compete Agreements in the Workplace Will Be banned in 2…
Effectively Controlling Conflict At Work: Practical Strateg…
All About Civility - Eliminating a Culture of Gossip Rumors…
AML Basics, Current Issues - Staying Compliant with the Reg…
Project Management for administrative professionals
Implementing a Robust Change Control Program - Key Elements…
Exempt vs Non-Exempt Employees: Understand the Difference a…
Zero Acceptance Sampling to Reduce Inspection Costs
3-Hour Excel Automation Boot Camp: Top Ten Excel Functions …
Remote Deposit Capture (RDC): Rules and Regulations - Legal…
I-9 Audits: Strengthening Your Immigration Compliance Strat…
Estate, Gift, and Generation-Skipping Transfer Taxes
Accounting For Non Accountants : Debit, Credits And Financi…
New Pregnancy Protections Regulations in the Workplace for …
Employee Documentation: Are You Collecting and Retaining Re…
What SECURE Act 2.0 Means for Tax Professionals